E. Ohman J or Asset Management AB Buys 500 Shares of West Pharmaceutical Services, Inc. (NYSE:WST)

E. Ohman J or Asset Management AB lifted its holdings in shares of West Pharmaceutical Services, Inc. (NYSE:WST) by 17.0% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 3,439 shares of the medical instruments supplier’s stock after purchasing an additional 500 shares during the quarter. E. Ohman J or Asset Management AB’s holdings in West Pharmaceutical Services were worth $1,126,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors also recently modified their holdings of WST. Baron Wealth Management LLC raised its holdings in shares of West Pharmaceutical Services by 1.9% during the fourth quarter. Baron Wealth Management LLC now owns 1,926 shares of the medical instruments supplier’s stock valued at $631,000 after acquiring an additional 35 shares in the last quarter. Exchange Traded Concepts LLC grew its stake in shares of West Pharmaceutical Services by 18.9% in the fourth quarter. Exchange Traded Concepts LLC now owns 239 shares of the medical instruments supplier’s stock worth $78,000 after acquiring an additional 38 shares during the last quarter. Covestor Ltd boosted its position in shares of West Pharmaceutical Services by 14.3% during the third quarter. Covestor Ltd now owns 320 shares of the medical instruments supplier’s stock valued at $96,000 after buying an additional 40 shares during the last quarter. KBC Group NV boosted its position in shares of West Pharmaceutical Services by 0.4% during the fourth quarter. KBC Group NV now owns 9,980 shares of the medical instruments supplier’s stock valued at $3,269,000 after buying an additional 42 shares during the last quarter. Finally, UMB Bank n.a. boosted its position in shares of West Pharmaceutical Services by 1.2% during the third quarter. UMB Bank n.a. now owns 3,941 shares of the medical instruments supplier’s stock valued at $1,183,000 after buying an additional 47 shares during the last quarter. Hedge funds and other institutional investors own 93.90% of the company’s stock.

Analyst Ratings Changes

Several research analysts have issued reports on WST shares. Citigroup began coverage on West Pharmaceutical Services in a research report on Wednesday, January 8th. They issued a “buy” rating and a $400.00 target price on the stock. Bank of America lifted their target price on West Pharmaceutical Services from $350.00 to $355.00 and gave the stock a “buy” rating in a report on Friday, December 13th. UBS Group upgraded West Pharmaceutical Services from a “neutral” rating to a “buy” rating and boosted their price objective for the company from $350.00 to $390.00 in a report on Thursday, December 12th. StockNews.com raised West Pharmaceutical Services from a “hold” rating to a “buy” rating in a research report on Friday, January 31st. Finally, Wolfe Research began coverage on West Pharmaceutical Services in a research report on Friday, December 13th. They issued a “peer perform” rating for the company. One analyst has rated the stock with a hold rating and six have issued a buy rating to the company’s stock. According to MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average target price of $430.20.

West Pharmaceutical Services Stock Up 1.4 %

West Pharmaceutical Services stock opened at $335.54 on Thursday. West Pharmaceutical Services, Inc. has a fifty-two week low of $265.00 and a fifty-two week high of $413.70. The company has a debt-to-equity ratio of 0.07, a quick ratio of 2.23 and a current ratio of 3.00. The company has a market capitalization of $24.30 billion, a P/E ratio of 49.78, a PEG ratio of 19.82 and a beta of 1.01. The stock has a 50-day simple moving average of $332.25 and a 200-day simple moving average of $314.42.

West Pharmaceutical Services Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, February 11th. Shareholders of record on Friday, February 7th will be given a dividend of $0.21 per share. This represents a $0.84 annualized dividend and a yield of 0.25%. The ex-dividend date is Friday, February 7th. West Pharmaceutical Services’s payout ratio is 12.46%.

West Pharmaceutical Services Company Profile

West Pharmaceutical Services, Inc designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products.